פרסומים אקדמיים אחרונים מאת סגל המרכז הרפואי

The association between lifetime cannabis use and dysthymia across six birth decades.

Livne O, Razon L, Rehm J, Hasin DS, Lev-Ran S.

J Affect Disord. 2018 Jul;234:327-334. doi: 10.1016/j.jad.2018.03.005. Epub 2018 Mar 16.

Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.

Feingold D, Rehm J, Factor H, Redler A, Lev-Ran S.

Depress Anxiety. 2018 Feb 27. doi: 10.1002/da.22735. [Epub ahead of print]

Fatal Overdoses of Opioids in Israel 2005-2014.

Feingold D, Goldberger N, Haklai Z, Lev-Ran S.

Eur Addict Res. 2017;23(6):276-283. doi: 10.1159/000485033. Epub 2017 Dec 21.

Primary Addictive Substances Used among Patients Treated in a Hospital-Based Addiction Medicine Service.

Feingold D, Lev-Ran S.

Isr J Psychiatry Relat Sci. 2017;54(2):41-46.

Adverse Reactions Associated With Cannabis Consumption as Evident From Search Engine Queries.

Yom-Tov E, Lev-Ran S.

JMIR Public Health Surveill. 2017 Oct 26;3(4):e77. doi: 10.2196/publichealth.8391.

Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder.

Taub S, Feingold D, Rehm J, Lev-Ran S.

Compr Psychiatry. 2018 Jan;80:89-96. doi: 10.1016/j.comppsych.2017.09.004. Epub 2017 Sep 13.

Misuse of prescription opioids among chronic pain patients suffering from anxiety: A cross-sectional analysis.

Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S.

Gen Hosp Psychiatry. 2017 Jul;47:36-42. doi: 10.1016/j.genhosppsych.2017.04.006. Epub 2017 May 1.

The Impact of 'Being There': Psychiatric Staff Attitudes on the Use of Restraint.

Dahan S, Levi G, Behrbalk P, Bronstein I, Hirschmann S, Lev-Ran S.

Psychiatr Q. 2018 Mar;89(1):191-199. doi: 10.1007/s11126-017-9524-9.

Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.

Lev-Ran S, Feingold D, Goodman C, Lerner AG.

Am J Addict. 2017 Sep;26(6):568-571. doi: 10.1111/ajad.12577. Epub 2017 Jun 27.

Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana.

Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S.

J Affect Disord. 2017 Aug 15;218:1-7. doi: 10.1016/j.jad.2017.04.026. Epub 2017 Apr 21.

Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study.

Feingold D, Rehm J, Lev-Ran S.

Psychiatry Res. 2017 May;251:225-234. doi: 10.1016/j.psychres.2017.02.027. Epub 2017 Feb 12.

Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain.

Feingold D, Goor-Aryeh I, Bril S, Delayahu Y, Lev-Ran S.

https://www.ncbi.nlm.nih.gov/pubmed/27888956

Dahan, S., Behrbalk, P., & Greenberger, C. (2016). Improving Adherence in Hospitalized Patients

Diagnosed With Schizophrenia: An Integrative One-on-One Intervention.

Archives of Psychiatric Nursing.‏